CCL5 and lung carcinoma: The decreased levels of RANTES in the H1975GR may be tumor-protective in the scenario of drug resistant lung cancer, given that high RANTES is sometimes associated with an improved patient survival [51], most likely as a result of enhanced cytotoxic T-cell recruitment and tumor cell killing, although further research is required to define the relationship between these correlations [52].